{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:17:15Z","timestamp":1765959435216,"version":"3.48.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,17]]},"DOI":"10.7759\/cureus.99429","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:07:26Z","timestamp":1765958846000},"source":"Crossref","is-referenced-by-count":0,"title":["Late-Onset X-linked Adrenoleukodystrophy: A Rare Cause of Progressive Spastic Paraparesis"],"prefix":"10.7759","author":[{"given":"Sofia","family":"Sequeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Velon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.09.015","article-title":"Adult-onset spastic paraparesis: an approach to diagnostic work-up","volume":"346","author":"Zhovtis Ryerson L","year":"2014","unstructured":"Zhovtis Ryerson L, Herbert J, Howard J, Kister I. Adult-onset spastic paraparesis: an approach to diagnostic work-up. J Neurol Sci. 2014, 346:43-50. 10.1016\/j.jns.2014.09.015","journal-title":"J Neurol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen M","year":"2012","unstructured":"Engelen M, Kemp S, de Visser M, van Geel BM, Wanders RJ, Aubourg P, Poll-The BT. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012, 7:51. 10.1186\/1750-1172-7-51","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0745-1","article-title":"Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach","volume":"30","author":"Sedel F","year":"2007","unstructured":"Sedel F, Fontaine B, Saudubray JM, Lyon-Caen O. Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach. J Inherit Metab Dis. 2007, 30:855-64. 10.1007\/s10545-007-0745-1","journal-title":"J Inherit Metab Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e328338313a","article-title":"Leukodystrophies with late disease onset: an update","volume":"23","author":"K\u00f6hler W","year":"2010","unstructured":"K\u00f6hler W. Leukodystrophies with late disease onset: an update. Curr Opin Neurol. 2010, 23:234-41. 10.1097\/WCO.0b013e328338313a","journal-title":"Curr Opin Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1008-6","article-title":"Disease progression in women with X-linked adrenoleukodystrophy is slow","volume":"14","author":"Huffnagel IC","year":"2019","unstructured":"Huffnagel IC, Dijkgraaf MG, Janssens GE, et al.. Disease progression in women with X-linked adrenoleukodystrophy is slow. Orphanet J Rare Dis. 2019, 14:30. 10.1186\/s13023-019-1008-6","journal-title":"Orphanet J Rare Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(20010201)49:2<186::aid-ana38>3.0.co;2-r","article-title":"Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy","volume":"49","author":"van Geel BM","year":"2001","unstructured":"van Geel BM, Bezman L, Loes DJ, et al.. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol.. 2001, 49:186-194. 10.1002\/1531-8249(20010201)49:2&lt;186::aid-ana38&gt;3.0.co;2-r","journal-title":"Ann Neurol."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.03.010","article-title":"Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS\/MS) method","volume":"97","author":"Hubbard WC","year":"2009","unstructured":"Hubbard WC, Moser AB, Liu AC, et al.. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS\/MS) method. Mol Genet Metab. 2009, 97:212-20. 10.1016\/j.ymgme.2009.03.010","journal-title":"Mol Genet Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2017.10.012","article-title":"Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy","volume":"122","author":"Huffnagel IC","year":"2017","unstructured":"Huffnagel IC, van de Beek MC, Showers AL, et al.. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy. Mol Genet Metab. 2017, 122:209-15. 10.1016\/j.ymgme.2017.10.012","journal-title":"Mol Genet Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.90","article-title":"Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history","volume":"12","author":"Kemp S","year":"2016","unstructured":"Kemp S, Huffnagel IC, Linthorst GE, Wanders RJ, Engelen M. Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol. 2016, 12:606-15. 10.1038\/nrendo.2016.90","journal-title":"Nat Rev Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"377","author":"Eichler F","year":"2017","unstructured":"Eichler F, Duncan C, Musolino PL, et al.. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med. 2017, 377:1630-8. 10.1056\/NEJMoa1700554","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009929","article-title":"Neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy","volume":"95","author":"Pierpont EI","year":"2020","unstructured":"Pierpont EI, Nascene DR, Shanley R, et al.. Neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy. Neurology. 2020, 95:e591-600. 10.1212\/WNL.0000000000009929","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/443571-late-onset-x-linked-adrenoleukodystrophy-a-rare-cause-of-progressive-spastic-paraparesis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:07:26Z","timestamp":1765958846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/443571-late-onset-x-linked-adrenoleukodystrophy-a-rare-cause-of-progressive-spastic-paraparesis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.99429","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}